Antiproliferative compounds and methods of use thereof
US-12029738-B2 · Jul 9, 2024 · US
This page is not indexed by search engines while we improve data quality.
Cathers Brian E patents
Cathers Brian E is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cathers Brian E |
| Total patents | 28 |
| First publication | Dec 31, 2015 |
| Latest publication | Jul 9, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Antiproliferative compounds and methods of use thereof
US-2024207255-A1 · Jun 27, 2024 · US
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US-11733233-B2 · Aug 22, 2023 · US
Antiproliferative compounds and methods of use thereof
US-2022387413-A1 · Dec 8, 2022 · US
Antiproliferative compounds and methods of use thereof
US-2022280505-A1 · Sep 8, 2022 · US
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US-11419861-B2 · Aug 23, 2022 · US
Antiproliferative compounds and methods of use thereof
US-11241423-B2 · Feb 8, 2022 · US
Antiproliferative compounds and methods of use thereof
US-11185543-B2 · Nov 30, 2021 · US
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
US-2021003557-A1 · Jan 7, 2021 · US
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
US-2021000813-A1 · Jan 7, 2021 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US-10830762-B2 · Nov 10, 2020 · US
Antiproliferative compounds and methods of use thereof
US-2020253964-A1 · Aug 13, 2020 · US
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US-10668057-B2 · Jun 2, 2020 · US
Antiproliferative compounds and methods of use thereof
US-2020163948-A1 · May 28, 2020 · US
Antiproliferative compounds and methods of use thereof
US-2019282567-A1 · Sep 19, 2019 · US
Antiproliferative compounds and methods of use thereof
US-10357489-B2 · Jul 23, 2019 · US
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
US-2019030019-A1 · Jan 31, 2019 · US
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
US-2019017998-A1 · Jan 17, 2019 · US
Antiproliferative compounds and methods of use thereof
US-2019008852-A1 · Jan 10, 2019 · US
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
US-10092555-B2 · Oct 9, 2018 · US
Use of biomarkers for predicting clinical sensitivity to cancer treatment
US-2018267043-A1 · Sep 20, 2018 · US
Antiproliferative compounds and methods of use thereof
US-2018221361-A1 · Aug 9, 2018 · US
Antiproliferative compounds and methods of use thereof
US-9968596-B2 · May 15, 2018 · US
Antiproliferative compounds and methods of use thereof
US-2018021325-A1 · Jan 25, 2018 · US
Antiproliferative compounds and methods of use thereof
US-9808451-B2 · Nov 7, 2017 · US
Antiproliferative compounds and methods of use thereof
US-2017007590-A1 · Jan 12, 2017 · US
Antiproliferative compounds and methods of use thereof
US-9499514-B2 · Nov 22, 2016 · US
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
US-2015374678-A1 · Dec 31, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Corp | 28 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 24 |
| A61K31/454 | 24 |
| C07D401/04 | 21 |
| A61P35/02 | 18 |
| A61K45/06 | 17 |